Veyron S Overview
Veyron S is one of a growing number of products manufactured in Hong Kong that are becoming well-known for the treatment of impotence. This particular brand is made by Veyron Enterprise and, although there is some relevant information about the company to be found online, there is no official website and limited details regarding Veyron S. All contact information for the company is available, and they can be contacted for more product –specific details. Unfortunately, the price of Veyron S is unknown and there are no customer testimonials provided nor any free samples or satisfaction guarantees.
Veyron S Product Details
Little is known about the Veyron S formula other than it contains all-natural ingredients, from both the plant and animal world. Results of clinical tests are not shown, but it is claimed that the product’s effects lasted up to 60 hours in trials. The full ingredient list is not published for Veyron S but it is known that it contains certain amounts of Oyster meat, a known aphrodisiac, Muira Puama, Saw Palmetto, Maca, Avena Sativa and Tribulus. This final ingredient is important for its ability to support production of Testosterone, the male sex hormone that helps support virility and sexual drive.
The formula is said to not cause unpleasant side effects and should not interact with other medications.
Good About Veyron S
- Veyron S has undergone clinical testing
- All manufacturer contact information is available
- The product can be used for mild to severe cases of impotence
- The formula contains Tribulus
Bad About Veyron S
- The cost of Veyron S is not known
- Dosage instructions are not provided
- A money back guarantee is not shown
- Product ingredient information is limited
- The formula does not contain L-Arginine
- Ordering details are not provided
Veyron S The Bottom Line
Veyron S seems to have received a lot of press in Asia, but it is still unknown in North America. Without knowing more about it, including important details such as full ingredient list, price etc., it is not likely to compete with impotence treatments available in the U.S.